Accession | GMS-65-3
URL copied to the clipboard |
Title | Degradation of RAD21 in HCT-116 |
Submit date | 2023-05-29 15:56:40 |
Last update date | 2023-05-29 15:54:56 |
Contact | GMSuite GENOMEMODALITY gmsuite AT hgc.jp The University of Tokyo |
Sharing | |
Total file size | 1.88 GB |
Keywords | Cohesin ChIP-seq Micro-C EU-seq RAD21 |
Experiment type | An auxin-inducible degron system destroys RAD21 in HCT-116 cell line. RAD21 is a core component of the cohesin complex.HCT-116 is a human colorectal carcinoma cell line. Auxin (IAA) treated samples. |
Summary | After Auxin (IAA) Treatment ChIP-seq AFF4, BRD4, CBP, CDK9, MAU2, MED1, NCBP1, NELFCD, RPB1, RAD21, S2P, SPT4, TAF1, TBP, P300, H3K27ac, H3K4me1 EU-seq in vivo 5-ethynyluridine (EU) labeling of nascent transcripts Micro-C |
Citation(s) |
Organism | Human |
Cell (Tissue) | HCT-116 |
Protocol | |
Data processing |
[1] | EU-seq (IAA treated, Rep1) accepted_hits.bam.sorted.bam (1.81 GB) Human (hg38); RNA-Seq |
BAM |
[2] | AFF4 narrow peaks (IAA treated) AFF4_np1_peaks.narrowPeak.scaled.bigwig (530.03 KB) Human (hg38); ChIP-Seq |
BW |
[3] | BRD4 narrow peaks in HCT-116 (IAA treated) BRD4_np1_peaks.narrowPeak.scaled.bigwig (3.35 MB) Human (hg38); ChIP-Seq |
BW |
[4] | CBP narrow peaks (IAA treated) CBP_np1_peaks.narrowPeak.scaled.bigwig (2.46 MB) Human (hg38); ChIP-Seq |
BW |
[5] | CDK9 narrow peaks (IAA treated) CDK9_np1_peaks.narrowPeak.scaled.bigwig (1.82 MB) Human (hg38); ChIP-Seq |
BW |
[6] | H3K27ac narrow peaks (IAA treated) H3K27ac_np1_peaks.narrowPeak.scaled.bigwig (6.00 MB) Human (hg38); ChIP-Seq |
BW |
[7] | H3K4me1 narrow peaks (IAA treated) H3K4me1_np1_peaks.narrowPeak.scaled.bigwig (8.00 MB) Human (hg38); ChIP-Seq |
BW |
[8] | MAU2 narrow peaks (IAA treated) MAU2_np1_peaks.narrowPeak.scaled.bigwig (395.77 KB) Human (hg38); ChIP-Seq |
BW |
[9] | MED1 narrow peaks (IAA treated, rep1) MED1_np1_peaks.narrowPeak.scaled.bigwig (3.38 MB) Human (hg38); ChIP-Seq |
BW |
[10] | MED1 narrow peaks (IAA treated, rep2) MED1_np2_peaks.narrowPeak.scaled.bigwig (2.23 MB) Human (hg38); ChIP-Seq |
BW |
[11] | NCBP1 narrow peaks (IAA treated) NCBP1_np1_peaks.narrowPeak.scaled.bigwig (1.63 MB) Human (hg38); ChIP-Seq |
BW |
[12] | NELFCD narrow peaks (IAA treated) NELFCD_np1_peaks.narrowPeak.scaled.bigwig (2.16 MB) Human (hg38); ChIP-Seq |
BW |
[13] | P300 narrow peaks (IAA treated) P300_np1_peaks.narrowPeak.scaled.bigwig (1.87 MB) Human (hg38); ChIP-Seq |
BW |
[14] | RPB1 narrow peaks (IAA treated, rep1) RPB1_np1_peaks.narrowPeak.scaled.bigwig (11.92 MB) Human (hg38); ChIP-Seq |
BW |
[15] | RPB1 narrow peaks (IAA treated, rep2) RPB1_np2_peaks.narrowPeak.scaled.bigwig (7.01 MB) Human (hg38); ChIP-Seq |
BW |
[16] | S2P narrow peaks (IAA treated) S2P_np1_peaks.narrowPeak.scaled.bigwig (9.17 MB) Human (hg38); ChIP-Seq |
BW |
[17] | SPT4 narrow peaks (IAA treated) SPT4_np1_peaks.narrowPeak.scaled.bigwig (7.25 MB) Human (hg38); ChIP-Seq |
BW |
[18] | TAF1 narrow peaks (IAA treated) TAF1_np1_peaks.narrowPeak.scaled.bigwig (2.75 MB) Human (hg38); ChIP-Seq |
BW |
[19] | TBP narrow peaks (IAA treated, rep1) TBP_np1_peaks.narrowPeak.scaled.bigwig (3.13 MB) Human (hg38); ChIP-Seq |
BW |
[20] | TBP narrow peaks (IAA treated, rep2) TBP_np2_peaks.narrowPeak.scaled.bigwig (3.04 MB) Human (hg38); ChIP-Seq |
BW |